Showing results 1 to 1 of 1
Issue Date | Title | Journal Title |
---|---|---|
2021 | Gemcitabine plus Nab-paclitaxel as a second-line treatment following FOLFIRINOX failure in advanced pancreatic cancer: a multicenter, single-arm, open-label, phase 2 trial | THERAPEUTIC ADVANCES IN MEDICAL ONCOLOGY |